The intertumoral and intratumoral heterogeneity of colorectal adenocarcinoma (CRC) at the morphologic level is poorly understood. Previously, we identified morphological patterns associated with CRC molecular subtypes and their distinct molecular motifs. Here we aimed to evaluate the heterogeneity of these patterns across CRC. Three pathologists evaluated dominant, secondary, and tertiary morphology on four sections from four different FFPE blocks per tumor in a pilot set of 22 CRCs. An AI-based image analysis tool was trained on these tumors to evaluate the morphologic heterogeneity on an extended set of 161 stage I-IV primary CRCs (n = 644 H&E sections). We found that most tumors had two or three different dominant morphotypes and the complex tubular (CT) morphotype was the most common. The CT morphotype showed no combinatorial preferences. Desmoplastic (DE) morphotype was rarely dominant and rarely combined with other dominant morphotypes. Mucinous (MU) morphotype was mostly combined with solid/trabecular (TB) and papillary (PP) morphotypes. Most tumors showed medium or high heterogeneity, but no associations were found between heterogeneity and clinical parameters. A higher proportion of DE morphotype was associated with higher T-stage, N-stage, distant metastases, AJCC stage, and shorter overall survival (OS) and relapse-free survival (RFS). A higher proportion of MU morphotype was associated with higher grade, right side, and microsatellite instability (MSI). PP morphotype was associated with earlier T- and N-stage, absence of metastases, and improved OS and RFS. CT was linked to left side, lower grade, and better survival in stage I-III patients. MSI tumors showed higher proportions of MU and TB, and lower CT and PP morphotypes. These findings suggest that morphological shifts accompany tumor progression and highlight the need for extensive sampling and AI-based analysis. In conclusion, we observed unexpectedly high intratumoral morphological heterogeneity of CRC and found that it is not heterogeneity per se, but the proportions of morphologies that are associated with clinical outcomes.

Berlin Institute of Health Berlin Germany

German Cancer Consortium Heidelberg Germany

Institute of Pathology Charité Universitätsmedizin Berlin Berlin Germany

Masaryk Memorial Cancer Institute Brno Czech Republic

Masarykova Univerzita RECETOX Brno Czech Republic

University Institute of Pathology University of Lausanne Lausanne Switzerland

See more in PubMed

Organisation mondiale de la santé, Centre international de recherche sur le cancer . Digestive System Tumours (World Health Organization Classification of Tumours) (5th edn). International Agency for Research on Cancer: Lyon, 2019.

Ono Y, Yilmaz O. Emerging and under‐recognised patterns of colorectal carcinoma morphologies: a comprehensive review. J Clin Pathol 2024; 77: 439–451. PubMed

Dietel M, Jöhrens K, Laffert MV, PubMed

Pang SW, Awi NJ, Armon S, PubMed PMC

Guinney J, Dienstmann R, Wang X, PubMed PMC

Popovici V, Budinská E, Dušek L, PubMed

Sirinukunwattana K, Domingo E, Richman SD, PubMed PMC

Budinská E, Hrivňáková M, Ivkovic TC, PubMed PMC

Budinska E, Popovici V, Tejpar S, PubMed PMC

R Core Team . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, 2024.

Whitney‐Miller CL. Impact of subspecialty sign‐out on interobserver variability and accuracy in gastrointestinal pathology. Surg Pathol Clin 2020; 13: 371–376. PubMed

Shia J, Schultz N, Kuk D, PubMed PMC

O'Brien MJ, Zhao Q, Yang S. Colorectal serrated pathway cancers and precursors. Histopathology 2015; 66: 49–65. PubMed

Patankar M, Väyrynen S, Tuomisto A, PubMed

Kuroda N, Oonishi K, Ohara M, PubMed

Remo A, Fassan M, Vanoli A, PubMed PMC

Sveen A, Kopetz S, Lothe RA. Biomarker‐guided therapy for colorectal cancer: strength in complexity. Nat Rev Clin Oncol 2020; 17: 11–32. PubMed PMC

Büttner J, Jöhrens K, Klauschen F, PubMed

Roepman P, Schlicker A, Tabernero J, PubMed PMC

Trinh A, Trumpi K, De Sousa E Melo F, PubMed

de Sousa E Melo F, Wang X, Jansen M, PubMed

Song N, Pogue‐Geile KL, Gavin PG, PubMed PMC

Minciuna CE, Tanase M, Manuc TE, PubMed PMC

Wood CS, Pennel KAF, Leslie H, PubMed PMC

Wang F, Long J, Li L, PubMed PMC

Qi J, Sun H, Zhang Y, PubMed PMC

Green JB, Timmcke AE, Mitchell WT, PubMed

Hu Q, Wang Y, Yao S, PubMed PMC

Ueno H, Ishiguro M, Nakatani E, PubMed PMC

Baisse B, Bouzourene H, Saraga EP, PubMed

Roelands J, Kuppen PJK, Ahmed EI, PubMed PMC

Ueno H, Jones A, Jass JR, PubMed